FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Elan topics
Folic Acid
Carbon Dioxide
Antibodies
Immune Response
High Energy
Inorganic Compounds
Electrolysis
Semiconductor Material
Semiconductor
Hydrogen Production From Water
Female Sexual Dysfunction
Dysfunction
Sexual Dysfunction
Mammography
Radiograph

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elan patents



      
           
This page is updated frequently with new Elan-related patent applications. Subscribe to the Elan RSS feed to automatically get the update: related Elan RSS feeds. RSS updates for this page: Elan RSS RSS


Date/App# patent app List of recent Elan-related patents
07/24/14
20140206957
 Method and optical system for evaluating concentrations of components in tissue patent thumbnailMethod and optical system for evaluating concentrations of components in tissue
A method and an optical system for evaluating the spatial distribution of the concentrations of components in tissue are disclosed. The novel detecting probe included in the optical system comprises plural optical fiber sets, each optical fiber set respectively comprises at least one source optical fiber and at least one detector optical fiber, the source optical fiber connects with the multi-wavelength light source, the source optical fiber delivers light from the multi-wavelength light source onto a tested tissue; and the angle between one optical fiber set and another optical fiber set is greater than 0° and less than and not equal to 180°.
07/24/14
20140205685
 Herbal combinations for treatment of a skin condition patent thumbnailHerbal combinations for treatment of a skin condition
A method and medicine for treating melanoma, bcc (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, comprising applying or injecting to an infected skin area of a patient diagnosed with melanoma, bcc (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, a treatment regimen that includes periodic doses of a molecular combination of emodin and digoxin and/or an herbal combination of da huang and sheng di huang.. .
07/17/14
20140199378
 New natural and synthetic compounds for treating cancer and other diseases patent thumbnailNew natural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
07/10/14
20140194632
 Method for screening for compounds selectively interacting with rad9 patent thumbnailMethod for screening for compounds selectively interacting with rad9
Natural and synthetic compounds of formulae ia-ie having a lactone structure, in particular securolide, have been determined to be effective anti-tumor compounds which target the hrad9 gene and/or protein encoded thereby or complex containing the protein and/or the p53 gene and/or protein. Securolide is cytoselective for mutants of hrad9 based on studies conducted in rad9 mutant yeast strains.
07/10/14
20140194495
 Cytotoxin compounds and methods of isolation patent thumbnailCytotoxin compounds and methods of isolation
The present invention concerns groups of compounds derived from tunicates of the synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the nci 60 cell line panel.
07/10/14
20140194469
 Histone demethylase inhibitors patent thumbnailHistone demethylase inhibitors
Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase.
07/10/14
20140193479
 Compositions and methods for treatment of mammalian skin patent thumbnailCompositions and methods for treatment of mammalian skin
Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure.
07/10/14
20140193478
 Compositions and methods for treatment on mammalian skin patent thumbnailCompositions and methods for treatment on mammalian skin
Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure.
07/10/14
20140193349
 Use of cannabinoid compounds for stimulating melanogenesis patent thumbnailUse of cannabinoid compounds for stimulating melanogenesis
It being understood that, when r3 and r4 together form an oxo group with the carbon atom which bears them and x represents an oxygen atom, then r1 cannot represent a hydroxymethyl group, as an agent for coloring keratin materials. It also relates to one of these specific cannabinoid compounds for use thereof in the treatment of vitiligo or pityriasis versicolor, to nontherapeutic cosmetic processes for coloring the skin or for treating canities, comprising the topical application to the skin and/or head hair, or the oral administration, of a composition comprising, in a physiologically acceptable medium, one of these cannabinoid compounds, and to a process for selecting an active agent which promotes the pigmentation of keratin materials..
07/03/14
20140188196
 Methods for weight treatment in animals utilizing narrow spectrum light patent thumbnailMethods for weight treatment in animals utilizing narrow spectrum light
Methods of weight treatment in animals are presented including: stimulating a retinal ganglia of the animal by an exposure to a narrow spectrum light. In some embodiments, the stimulating the retinal ganglia of the animal is associated with a stimulation of melanopsin.
07/03/14
20140187469
Aqueous formulation for dispensing as a spray polymeric microcapsules containing at least one active ingredient
An aqueous formulation for dispensing as a spray polymeric microcapsules containing at least one active ingredient, the aqueous formulation comprising: (i) water; (ii) polymeric microcapsules having an oil-soluble core containing the at least one active ingredient; (iii) a cross linked acrylic acid co-polymer; (iv) a neutralising amine for activating the cross linked acrylic acid copolymer to form a gel suspension for the polymeric microcapsules whereby the polymeric microcapsules are suspended in the water; (v) a chelant for protecting the aqueous formulation against destabilisation by excessive metal ions; and (vi) an inhibitor for inhibiting bacterial growth in the water.. .
07/03/14
20140186295
Methods and compositions for the treatment of cancer
Described herein are methods for the treatment of cancer (e.g. Melanoma, lung cancer, or other cancers).
06/26/14
20140179736
Method of treating cancer and bone cancer pain
This invention is directed to the treatment of cancer, particularly lung cancer, breast cancer, melanoma, renal cell carcinoma, thyroid cancer that has metastasized to the bone. The invention is also directed to a method for treating bone cancer pain in an individual in need of such treatment comprising administering to the individual an effective amount of a compound of formula i..
06/26/14
20140179693
Methods for treating vascular leak syndrome
Disclosed are methods for treating vascular leak syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, inflammatory bowel disease.
06/26/14
20140179525
Herbicidal compositions comprising fluroxypyr and flumetsulam
Herbicidal compositions containing (a) fluoroxypyr or an agriculturally acceptable salt or ester thereof and (b) flumetsulam or an agriculturally acceptable salt thereof provide synergistic herbicidal control of undesirable vegetation, e.g., in wheat, barley, oats, rye, sugarcane, rice, sorghum, corn/maize, soybean, rice, sunflower, canola/oilseed rape, sugarcane, sorghum, cotton, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, industrial vegetation management and rights-of-way; or crops comprising an aad-12 gene. Also provided herein are methods of using herbicidal compositions containing (a) fluoroxypyr or an agriculturally acceptable salt or ester thereof and (b) flumetsulam or an agriculturally acceptable salt thereof..
06/26/14
20140178430
Idna vaccines and methods for using the same
Described herein are idna vectors and vaccines and methods for using the same. The idna generates live attenuated vaccines in eukaryotic cells in vitro or in vivo for pathogenic rna viruses, particularly yellow fever virus and venezuelan equine encephalitis virus.
06/26/14
20140178376
Method of inhibiting osteoclast activity
Methods for inhibiting osteoclastogenesis by administering a soluble rank polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer..
06/26/14
20140178319
Modulation of melanogenesis by modification of tyrosinase by palmitoylation
Compositions and methods for modulating melanogenesis by modifying tyrosinase palmitoylation are provided.. .
06/26/14
20140177808
Rapidly switching dual energy x-ray source
A dual energy x-ray source for use in homeland security, medical, non-destructive testing, and other markets includes a power supply, and a single x-ray tube. The x-ray tube includes two cathodes, and a single anode.
06/19/14
20140172322
Anti-terrorism water quality monitoring system
An anti-terrorism water quality monitoring system for continuously monitoring a potable water treatment system and related potable water distribution network that provides potable water to a municipality, city, housing development or other potable water consumer. The system includes the collection of data from the water distribution system and from the water treatment facility and from advanced separation processes which are integrated into analytical instruments.
06/19/14
20140171432
Histone demethylase inhibitors
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted 3-aminopyridine derivative compounds, substituted 3-aminopyridazine derivative compounds, and pharmaceutical compositions comprising said compounds.
06/19/14
20140171376
Light-sensitive chimeric gpcr protein
A light-sensitive chimeric protein comprising domains from at least two members of the g-protein-coupled-receptor (gpcr) protein super family, which are fused to yield a light-sensitive gpcr chimera capable of coupling a light signal to the signaling cascade of the metabotropic glutamate receptor 6 (mglur6) is provided for medical therapy and for the manufacture of medicaments for improving vision, in particular for treating loss of vision resulting from retinal photoreceptor degeneration. A first of the at least two gpcr family members contributes domains which mediate the light-sensitivity to the chimeric light-sensitive gpcr protein.
06/19/14
20140169698
Method for image fusion based on principal component analysis
An image fusion method combines absorption, differential phase contrast and dark-field (scattering) signals obtained with x-ray phase contrast sensitive techniques, such as an arrangement of gratings. The process fuses the absorption and dark-field signals by principal component analysis.
06/19/14
20140167024
Display apparatus
Provided is a display apparatus and a method of manufacture. The display apparatus includes a first substrate with a plurality of organic electroluminescence devices, a second substrate with a color filter, the second substrate facing the first substrate, and an adhesive layer disposed between the first substrate and the second substrate so as to cover the plurality of organic electroluminescence devices, the adhesive layer being made of a material selected from the group consisting of a phenol resin, a melanin resin, an unsaturated polyester resin, an epoxy resin, a silicon resin and a polyurethane resin..
06/12/14
20140163925
Anti-terrorism water quality monitoring system
An anti-terrorism water quality monitoring system for continuously monitoring a potable water treatment system and related potable water distribution network that provides potable water to a municipality, city, housing development or other potable water consumer. The system includes the collection of data from the water distribution system and from the water treatment facility and from advanced separation processes which are integrated into analytical instruments.
06/12/14
20140161806
Immunogenic synthetic glycoconjugate for the immunotherapy of melanoma
Wherein x is o, nh, s, ch2; l is a linker that is a divalent spacer; a is an adjuvant or carrier that is an immunogenic molecule or an immunogenic particle; and wherein bonds between linker and saccharide moiety and between linker and carrier are of covalent type; wherein the linker l presents a chemical structure suitable to space the saccharide moiety and the carrier by 7-30 atoms when the adjuvant/carrier a is a biomacromolecule or by 19-30 atoms when the adjuvant/carrier a is a metallic nanoparticle; wherein the carrier/adjuvant a can be selected among a macromolecule, a macrocycle, a dendrimer, a liposome, a nanoparticle, an oligosaccharide featuring from two to five monosaccharidic units or cells like dendritic cells.. .
06/12/14
20140160569
Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles
The present disclosure describes systems, methods, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling light exposure to melanopsin ganglion cells in a retina over the action potential spectrum of the melanopsin cells of the human eye and a visual spectral response of the human eye. Embodiments of an optical filter are described.
06/05/14
20140155470
Pla2r1 as anti-tumoral compound and as biomarker for the detection of cancer
Compositions comprising a polynucleotide of human pla2r1, a polypeptide of human pla2r1 or an extracellular fragment of human pla2r1 for use in the treatment of cancer in particular breast cancer, pancreatic cancer, colorectal cancer, kidney cancer and melanoma.. .
06/05/14
20140155304
Anticorrosive composition
The present invention relates to the discovery that melanoidins, and higher molecular weight fractions of products containing melanoidins, provide significant corrosive inhibition, which render these melanoidins suitable for use as anticorrosive agents in corrosive environments. In addition to being highly anticorrosive, the melanoidins of the present invention are environmentally friendly and non-toxic, and can be found in animal food and in human foodstuffs..
06/05/14
20140154684
Diagnosis of melanoma and solar lentigo by nucleic acid analysis
The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin.
06/05/14
20140154194
Skin whitening composition containing chia seed extract
A topical composition includes an alcohol-extracted salvia hispanica seed extract in a glycol carrier in an amount effective for inhibiting melanin content in an individual. The extract may be extracted in a c1-c4 ethanol and re-suspended in a glycol carrier with one or more permeation enhancers.
05/29/14
20140148496
Therapeutic and diagnostic method for ataxia-telangiectasia
Atm kinase is shown to regulate proteasome-mediated protein turnover through suppression of the expression of the ubiquitin-like protein isg15 (interferon stimulated gene 15). Silencing of the isg15 pathway restored both the ubiquitin and autophagy pathways, and the uv-mediated degradation of their substrates in a-t cells.
05/29/14
20140147920
Specific nnos inhibitors for the therapy and prevention of human melanoma
Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.. .
05/29/14
20140147385
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
The present invention is directed to novel non-invasive diagnostic tools/compounds comprising a cyclic peptide wherein the compound binds to a msh receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers.
05/22/14
20140142152
Methods and compounds for treating cancer
The invention includes, in part, methods and compounds for treating cancer including, but not limited to gliomas, melanomas, and neuroblastomas. In some embodiments of the invention, a glyceryltriacetate compound is administered to a subject in an amount effective to treat or prevent a cancer in the subject..
05/22/14
20140141431
Use of erbb4 as a prognostic and therapeutic marker for melanoma
Members of the protein tyrosine kinase (ptk) family are highly mutated in patients with melanoma. Described herein are novel somatic mutations in the erbb4 gene that result in increased kinase activity, transformation ability and anchorage-independent growth.
05/22/14
20140140990
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
Novel antibodies and antigen binding fragments that specifically bind to kaag1 and which may be used in the treatment, detection and diagnosis of cancer comprising kaag1-expressing cells are disclosed herein. Cells expressing the antibodies and antigen binding fragments as well as methods of detecting and treating cancer using the antibodies and fragments are also disclosed.
05/22/14
20140140959
Energy absorbing-based diagnostic and therapeutic methods employing nucleic acid molecules encoding chromophore-producing enzymes
Provided are diagnostic and therapeutic methods using a composition containing a nucleic acid encoding a chromophore-producing enzyme(s), such as a melanin-producing enzyme or enzymes. The nucleic acid molecules can be used for directed or localized delivery to tumors or other cells associated with disease resulting in production of a chromophore product that can be used for diagnosis and therapy, including of tumors and metastases..
05/22/14
20140139803
Ophthalmic lenses with melanin and ocular lens pigment having low fluorescence
Fluorescence as a new source of haze caused by the light-filtering agent in ophthalmic lenses is introduced. A transparent ophthalmic lens comprising melanin as the light filtering agent with reduced fluorescence from melanin is described and the techniques used to quench the melanin fluorescence..
05/22/14
20140138085
Heterogeneous proppant placement in a fracture with removable channelant fill
A method of heterogeneous proppant placement in a subterranean fracture is disclosed. The method comprises injecting well treatment fluid including proppant (16) and proppant-spacing filler material called a channelant (18) through a wellbore (10) into the fracture (20), heterogeneously placing the proppant in the fracture in a plurality of proppant clusters or islands (22) spaced apart by the channelant (24), and removing the channelant filler material (24) to form open channels (26) around the pillars (28) for fluid flow from the formation (14) through the fracture (20) toward the wellbore (10).


Popular terms: [SEARCH]

Elan topics: Folic Acid, Carbon Dioxide, Antibodies, Immune Response, High Energy, Inorganic Compounds, Electrolysis, Semiconductor Material, Semiconductor, Hydrogen Production From Water, Female Sexual Dysfunction, Dysfunction, Sexual Dysfunction, Mammography, Radiograph

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.6834

3031

71 - 0 - 71